May 5, 2023 07:07 AM EDT

Maria Fardis ends a two-year CEO hiatus; More leadership turnover on the menu at Galapagos

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Following her resignation from Iovance, Maria Fardis pivoted to Frazier Life Sciences as a venture partner. But she’s back in the saddle at a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Maria Fardis ends a two-year CEO hiatus; More leadership turnover on the menu at Galapagos

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Patient dies in Neurogene's Rett syndrome study

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Are programs with compounded GLP-1s safe for your population?

Maria Fardis ends a two-year CEO hia­tus; More lead­er­ship turnover on the menu at Gala­pa­gos

Copy Chief

Editor

Sign up to read this article for free.

Maria Fardis ends a two-year CEO hiatus; More leadership turnover on the menu at Galapagos